An encouraging Opdivo/Yervoy study was presented at ASCO recently, which gave me a little more hope for the future.
onclive.com/view/nivolumab-...
Yervoy (ipilimumab) is an anti-CTLA-4, which apparently has higher risk of serious side-effects than some other immuno drugs.
I wonder if anyone here can comment on their experience with yervoy/opdivo? Did it help you? Did you have manageable side effects?